Related Experiment Video
Updated: Jul 13, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Cutaneous tuberculosis--a study of 400 cases.
1Deptt. of Dermatology & Venereology, Bangabandhu Sheikh Mujib Medical University, Dhaka.
Bangladesh Medical Research Council Bulletin
|August 1, 2007
Summary
This study investigated cutaneous tuberculosis (TB) in Bangladesh, finding Tuberculosis verrucosa cutis to be the most common form. All patients received effective combined antitubercular therapy.
Area of Science:
- Dermatology
- Infectious Diseases
- Microbiology
Background:
- Cutaneous tuberculosis (TB) presents diverse clinical manifestations.
- Accurate diagnosis and management are crucial for patient outcomes.
- Epidemiological data on cutaneous TB forms in specific regions are valuable.
Purpose of the Study:
- To prospectively analyze the clinical presentation and diagnosis of cutaneous tuberculosis.
- To determine the prevalence of different clinical forms of cutaneous TB.
- To evaluate treatment outcomes for patients with cutaneous TB.
Main Methods:
- A prospective study involving 400 patients with clinical signs of cutaneous TB.
- Clinical diagnosis was confirmed through histopathological examination.
- Data collected included patient demographics, clinical presentation, and diagnosis.
Main Results:
- The study included 400 cases, with 65% males and 35% females.
- Tuberculosis verrucosa cutis was the most prevalent form (50%), followed by Lupus vulgaris (40%) and Scrofuloderma (10%).
- Combined antitubercular therapy was administered to all patients.
Conclusions:
- Tuberculosis verrucosa cutis is the predominant form of cutaneous TB in the studied population.
- Histopathological confirmation is essential for diagnosing cutaneous TB.
- Combined antitubercular therapy is the standard treatment approach.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...